Financial Times’ David Firn reports that an honest-to-goodness hES clinical trial is ready to start for the improvement of sensory motor abilities lost in stroke.
Labels: clinical trials, hESC, ReNeuron, stem cell therapy, stroke
Latest Tweets
-
RT @Duncande: My latest for Atlantic: The Brain-Computer Interface That Let a Quadriplegic Woman Move a Cup - The Atlantic t.co/6kSgi61x Time ago 4 Hours
- #Bioethics News: Vatican Academy Struggles With Internal Dissent Over Outreach to Biomedical Re... t.co/DxPEQpTB #bioethics #AJOB Time ago 4 Hours
- RT @DiscoverMag: FDA approves 20 minute, $18 take-home HIV test: t.co/9UC6qJsV Time ago 5 Hours
- #Bioethics News: Health Exchanges’ Sharing of Patient Data Heightens Privacy Concerns t.co/kwZndQy9 #bioethics #AJOB Time ago 6 Hours
- RT @sciencemagazine: What's a genome worth in the clinic? #SciTM t.co/miDDIc60 Time ago 9 Hours
Follow @bioethics_net on twitter.
-